Re: Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy

J Natl Cancer Inst. 2009 Dec 16;101(24):1735-6; author reply 1736-7. doi: 10.1093/jnci/djp402.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anthracyclines / administration & dosage
  • Antigens, Neoplasm / genetics
  • Antigens, Neoplasm / metabolism*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / enzymology*
  • Breast Neoplasms / metabolism
  • Chemotherapy, Adjuvant
  • DNA Topoisomerases, Type II / genetics
  • DNA Topoisomerases, Type II / metabolism*
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Female
  • Gene Deletion
  • Gene Expression Regulation, Neoplastic
  • Humans
  • In Situ Hybridization, Fluorescence
  • Predictive Value of Tests
  • Receptor, ErbB-2 / metabolism
  • Up-Regulation

Substances

  • Anthracyclines
  • Antigens, Neoplasm
  • DNA-Binding Proteins
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • DNA Topoisomerases, Type II